Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.

McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH; Project MinE GWAS Consortium.; Schizophrenia Working Group of the Psychiatric Genomics Consortium..

Nat Commun. 2017 Mar 21;8:14774. doi: 10.1038/ncomms14774.

2.

Mortality in individuals with disruptive behavior disorders diagnosed by specialist services - A nationwide cohort study.

Scott JG, Giørtz Pedersen M, Erskine HE, Bikic A, Demontis D, McGrath JJ, Dalsgaard S.

Psychiatry Res. 2017 May;251:255-260. doi: 10.1016/j.psychres.2017.02.029. Epub 2017 Feb 13.

PMID:
28219025
3.

Whole-exome sequencing of individuals from an isolated population implicates rare risk variants in bipolar disorder.

Lescai F, Als TD, Li Q, Nyegaard M, Andorsdottir G, Biskopstø M, Hedemand A, Fiorentino A, O'Brien N, Jarram A, Liang J, Grove J, Pallesen J, Eickhardt E, Mattheisen M, Bolund L, Demontis D, Wang AG, McQuillin A, Mors O, Wang J, Børglum AD.

Transl Psychiatry. 2017 Feb 14;7(2):e1034. doi: 10.1038/tp.2017.3.

PMID:
28195573
4.

Soluble sortilin is present in excess and positively correlates with progranulin in CSF of aging individuals.

Molgaard S, Demontis D, Nicholson AM, Finch NA, Petersen RC, Petersen CM, Rademakers R, Nykjaer A, Glerup S.

Exp Gerontol. 2016 Nov;84:96-100. doi: 10.1016/j.exger.2016.09.002. Epub 2016 Sep 7.

PMID:
27612602
5.

Covariance Association Test (CVAT) Identifies Genetic Markers Associated with Schizophrenia in Functionally Associated Biological Processes.

Rohde PD, Demontis D, Cuyabano BC; Genomic Medicine for Schizophrenia Group., Børglum AD, Sørensen P.

Genetics. 2016 Aug;203(4):1901-13. doi: 10.1534/genetics.116.189498. Epub 2016 Jun 17.

PMID:
27317683
6.

CACNA1C hypermethylation is associated with bipolar disorder.

Starnawska A, Demontis D, Pen A, Hedemand A, Nielsen AL, Staunstrup NH, Grove J, Als TD, Jarram A, O'Brien NL, Mors O, McQuillin A, Børglum AD, Nyegaard M.

Transl Psychiatry. 2016 Jun 7;6(6):e831. doi: 10.1038/tp.2016.99.

7.

Whole-exome sequencing implicates DGKH as a risk gene for panic disorder in the Faroese population.

Gregersen NO, Lescai F, Liang J, Li Q, Als T, Buttenschøn HN, Hedemand A, Biskopstø M, Wang J, Wang AG, Børglum AD, Mors O, Demontis D.

Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1013-1022. doi: 10.1002/ajmg.b.32464. Epub 2016 Jun 3.

PMID:
27255576
8.

Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment.

Amidi A, Agerbæk M, Wu LM, Pedersen AD, Mehlsen M, Clausen CR, Demontis D, Børglum AD, Harbøll A, Zachariae R.

Brain Imaging Behav. 2016 May 30. [Epub ahead of print]

PMID:
27240852
9.

Whole-Exome Sequencing Reveals Increased Burden of Rare Functional and Disruptive Variants in Candidate Risk Genes in Individuals With Persistent Attention-Deficit/Hyperactivity Disorder.

Demontis D, Lescai F, Børglum A, Glerup S, Østergaard SD, Mors O, Li Q, Liang J, Jiang H, Li Y, Wang J, Lesch KP, Reif A, Buitelaar JK, Franke B.

J Am Acad Child Adolesc Psychiatry. 2016 Jun;55(6):521-3. doi: 10.1016/j.jaac.2016.03.009. No abstract available.

PMID:
27238071
10.

Hypomethylation of FAM63B in bipolar disorder patients.

Starnawska A, Demontis D, McQuillin A, O'Brien NL, Staunstrup NH, Mors O, Nielsen AL, Børglum AD, Nyegaard M.

Clin Epigenetics. 2016 May 11;8:52. doi: 10.1186/s13148-016-0221-6. eCollection 2016.

11.

Identification of the BRD1 interaction network and its impact on mental disorder risk.

Fryland T, Christensen JH, Pallesen J, Mattheisen M, Palmfeldt J, Bak M, Grove J, Demontis D, Blechingberg J, Ooi HS, Nyegaard M, Hauberg ME, Tommerup N, Gregersen N, Mors O, Corydon TJ, Nielsen AL, Børglum AD.

Genome Med. 2016 May 3;8(1):53. doi: 10.1186/s13073-016-0308-x.

12.

Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population.

Robinson EB, St Pourcain B, Anttila V, Kosmicki JA, Bulik-Sullivan B, Grove J, Maller J, Samocha KE, Sanders SJ, Ripke S, Martin J, Hollegaard MV, Werge T, Hougaard DM; iPSYCH-SSI-Broad Autism Group., Neale BM, Evans DM, Skuse D, Mortensen PB, Børglum AD, Ronald A, Smith GD, Daly MJ.

Nat Genet. 2016 May;48(5):552-5. doi: 10.1038/ng.3529. Epub 2016 Mar 21.

13.

Testing candidate genes for attention-deficit/hyperactivity disorder in fruit flies using a high throughput assay for complex behavior.

Rohde PD, Madsen LS, Neumann Arvidson SM, Loeschcke V, Demontis D, Kristensen TN.

Fly (Austin). 2016 Jan 2;10(1):25-34. doi: 10.1080/19336934.2016.1158365. Epub 2016 Mar 8.

14.

Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept.

Franke B, Stein JL, Ripke S, Anttila V, Hibar DP, van Hulzen KJ, Arias-Vasquez A, Smoller JW, Nichols TE, Neale MC, McIntosh AM, Lee P, McMahon FJ, Meyer-Lindenberg A, Mattheisen M, Andreassen OA, Gruber O, Sachdev PS, Roiz-Santiañez R, Saykin AJ, Ehrlich S, Mather KA, Turner JA, Schwarz E, Thalamuthu A, Yao Y, Ho YY, Martin NG, Wright MJ; Schizophrenia Working Group of the Psychiatric Genomics Consortium.; Psychosis Endophenotypes International Consortium.; Wellcome Trust Case Control Consortium 2.; Enigma Consortium., O'Donovan MC, Thompson PM, Neale BM, Medland SE, Sullivan PF.

Nat Neurosci. 2016 Mar;19(3):420-31. doi: 10.1038/nn.4228. Epub 2016 Feb 1.

15.

Schizophrenia risk from complex variation of complement component 4.

Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J, Baum M, Van Doren V, Genovese G, Rose SA, Handsaker RE; Schizophrenia Working Group of the Psychiatric Genomics Consortium., Daly MJ, Carroll MC, Stevens B, McCarroll SA.

Nature. 2016 Feb 11;530(7589):177-83. doi: 10.1038/nature16549. Epub 2016 Jan 27.

16.

Discovery, genotyping and characterization of structural variation and novel sequence at single nucleotide resolution from de novo genome assemblies on a population scale.

Liu S, Huang S, Rao J, Ye W; Genome Denmark ConsortiumII., Krogh A, Wang J.

Gigascience. 2015 Dec 24;4:64. doi: 10.1186/s13742-015-0103-4. eCollection 2015.

17.

Genome-wide analyses suggest parallel selection for universal traits may eclipse local environmental selection in a highly mobile carnivore.

Stronen AV, Jędrzejewska B, Pertoldi C, Demontis D, Randi E, Niedziałkowska M, Borowik T, Sidorovich VE, Kusak J, Kojola I, Karamanlidis AA, Ozolins J, Dumenko V, Czarnomska SD.

Ecol Evol. 2015 Sep 22;5(19):4410-25. doi: 10.1002/ece3.1695. eCollection 2015 Oct.

18.

Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness.

Bigdeli TB, Ripke S, Bacanu SA, Lee SH, Wray NR, Gejman PV, Rietschel M, Cichon S, St Clair D, Corvin A, Kirov G, McQuillin A, Gurling H, Rujescu D, Andreassen OA, Werge T, Blackwood DH, Pato CN, Pato MT, Malhotra AK, O'Donovan MC, Kendler KS, Fanous AH; Schizophrenia Working Group of the Psychiatric Genomics Consortium..

Am J Med Genet B Neuropsychiatr Genet. 2016 Mar;171B(2):276-89. doi: 10.1002/ajmg.b.32402. Epub 2015 Dec 11.

PMID:
26663532
19.

Increased serum levels of sortilin are associated with depression and correlated with BDNF and VEGF.

Buttenschøn HN, Demontis D, Kaas M, Elfving B, Mølgaard S, Gustafsen C, Kaerlev L, Petersen CM, Børglum AD, Mors O, Glerup S.

Transl Psychiatry. 2015 Nov 10;5:e677. doi: 10.1038/tp.2015.167.

20.

Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis.

Loh PR, Bhatia G, Gusev A, Finucane HK, Bulik-Sullivan BK, Pollack SJ; Schizophrenia Working Group of Psychiatric Genomics Consortium., de Candia TR, Lee SH, Wray NR, Kendler KS, O'Donovan MC, Neale BM, Patterson N, Price AL.

Nat Genet. 2015 Dec;47(12):1385-92. doi: 10.1038/ng.3431. Epub 2015 Nov 2.

Supplemental Content

Loading ...
Support Center